Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Histogenics in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a -100.00% upside from the last price of $2.42.
Current Consensus is
The current consensus among 0 polled investment analysts is to n/a stock in Histogenics. This N/A consensus rating has held steady for over two years.